欧美极品

• share
• favorite_border

Chronic kidney disease is a progressive condition that affects more than 10% of the general population worldwide, amounting to 800 million individuals.1 Glomerular diseases (GD), excluding diabetic nephropathy, account for approximately 25% of the cases of kidney diseases worldwide.2 Given the magnitude of long-term morbidity from GD鈥� particularly the frequent manifestation in younger patients鈥攄iagnosing it efficiently and optimizing management to control diseases and prevent progressive kidney diseases is paramount.

• share
• favorite_border

Largest Global Gathering of Kidney Professionals Expands Program to Include More Breaking Research and Focused Discussions on Key Public Health and Policy Issues

• share
• favorite_border

ASN Kidney Translation Series podcast episode, led by Matt Sparks, related to the ASN New Initiative Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases.

• share
• favorite_border

To promote high-quality, person-directed care across the spectrum of kidney health and diseases the American Society of Nephrology (ASN) is releasing its inaugural Kidney Health Guidance (KHG) on the Management of Obesity in Persons Living with Kidney Diseases in the Journal of the American Society of Nephrology (JASN) on September 18, 2024.

• share
• favorite_border

The 2024 grant recipients, listed below, will extend this trajectory of achievement, and continue to improve quality of life for those living with kidney diseases.

• share
• favorite_border

The American Society of Nephrology (ASN) applauds the House Energy and Commerce Committee for unanimously passing the Honor Our Living Donors Act (H.R. 6020), to ensure that only the income of a living donor can be considered when determining eligibility for federal financial assistance provided to living donors. The bipartisan legislation now awaits action on the House floor and in the Senate.

• share
• favorite_border

The long-awaited Increasing Organ Transplant Access (IOTA) Model was released yesterday by the Center for Medicare and Medicaid Innovation (CMMI) focusing on increasing patients鈥� access to kidney transplantation across the United States.

• share
• favorite_border

APOL1 Kidney Disease (APOL1 KD) is a genetic condition that affects people who carry a high-risk APOL1 gene variant. Most people with those variants are of African ancestry.

• share
• favorite_border

Today, leaders from the American Society of Nephrology (ASN) will meet with their congressional delegations and call for their support of an $8 million increase for the Health Resources and Services Administration (HRSA) Organ Transplantation Program in FY 25 This funding, totaling $67 million, will be used to continue Congress鈥� commitment to people seeking a transplant and will implement reforms to modernize the transplant system and make transplant care more accessible.

• share
• favorite_border

Nature Reviews Nephrology published a landmark international consensus statement titled "Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus." Authored by a coalition of leading experts, stakeholders, and nephrology societies, the publication highlights critical policy, advocacy, and implementation needs to alleviate the growing burden of kidney disease worldwide.

• share
• favorite_border

Delivering on its commitment to increase Americans鈥� access to kidney transplant by improving the transparency and efficiency of our nation鈥檚 transplant network, Congress this week approved a much-needed $23 million federal funding increase in fiscal year (FY) 2024 for the Health Resources and Services Administration (HRSA), the agency responsible for overseeing the Organ Procurement and Transplantation Network (OPTN).

• share
• favorite_border

The American Society of Nephrology (ASN) and Home Dialysis University (HDU) launched a collaboration in 2023 to improve nephrology trainees鈥� knowledge, proficiency, and exposure to home dialysis therapies.

• share
• favorite_border

The American Society of Nephrology (ASN) commends congressional leaders on the House Ways and Means committee for advancing the Kidney PATIENT Act, bipartisan legislation to maintain patient access to oral-only medications by retaining coverage through Medicare Part D. More than 500,000 patients undergoing dialysis require numerous medications to manage their health, and, for many patients this includes certain oral-only medications, such as phosphate binders. These vital oral-only medications are best dispensed by pharmacies, who have dedicated infrastructure suited to promoting at-home medication adherence and are more accessible to patients.

• share
• favorite_border

At a hearing today focused on supporting patients with rare diseases, the House Energy and Commerce Health Subcommittee will consider Honor Our Living Donors Act (H.R. 6020), legislation to improve support for living organ donors.

• share
• favorite_border

The American Society of Nephrology (ASN) is pleased to announce that Deidra C. Crews, MD, ScM, FASN, will become the society鈥檚 next president. Dr. Crews, who succeeds Michelle A. Josephson, MD, FASN, will assume her new role on January 1, 2024.

• share
• favorite_border

Compared with kidney transplant recipients who did not receive sodium-glucose cotransporter-2 inhibitors, those treated with the medications had lower risks of experiencing kidney transplant failure, kidney transplant rejection, major adverse cardiac events, all-cause mortality, and genitourinary infections.

• share
• favorite_border

By examining the gene expression patterns of single cells from human fetal kidneys, researchers created a map that demonstrates the trajectories of cell states in the developing kidney and that identifies characteristics associated with kidney diseases.

• share
• favorite_border

Results from the phase 3 SCORED trial indicate that sotagliflozin protects kidney and heart health in individuals with type 2 diabetes and chronic kidney disease.

• share
• favorite_border

In a recent analysis of US data, Black patients with kidney failure experienced survival advantages compared with White patients when county-level structural racism was low, but they experienced survival disadvantages compared with White patients at higher levels of structural racism.